Stay updated on Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Sign up to get notified when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.

Latest updates to the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3, indicating a minor update to the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe update shows a revision label change from v3.4.1 to v3.4.2, with no visible changes to the study content, eligibility criteria, results, locations, or other core information on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page header. This appears to be a metadata/version update with no visible changes to study content, eligibility criteria, or locations.SummaryDifference0.0%

- Check49 days agoChange DetectedAdded a glossary toggle and the label 'Last Update Submitted that Met QC Criteria'; updated wording/capitalization for 'No FEAR Act Data' and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded the Locations section listing study sites by state (e.g., Alabama, Arizona, California, Colorado, etc.) and updated the revision to v3.3.3.SummaryDifference2%

Stay in the know with updates to Inhaled Treprostinil in COPD-Associated PH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Treprostinil in COPD-Associated PH Clinical Trial page.